insights_auto
Why is MBIO down 4.24%?
Dive Deeperchevron_right
MBIO:NASDAQ
Mustang Bio Inc
$0.49
arrow_downward
-4.24%(-0.021) 1D
Sep 29, 11:33:33 AM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MBIO...
Open
$0.50
High
$0.51
Low
$0.49
Mkt. cap
3.66M
Avg. vol.
22.47K
Volume
37.18K
52-wk high
$1.84
52-wk low
$0.47
EPS
-$0.46
Beta
2.05
Shares outstanding
6.73M
No. of employees
4
Open
$0.50
High
$0.51
Low
$0.49
Mkt. cap
3.66M
Avg. vol.
22.47K
Volume
37.18K
52-wk high
$1.84
52-wk low
$0.47
EPS
-$0.46
Beta
2.05
Shares outstanding
6.73M
No. of employees
4
Profile
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
About Mustang Bio Inc
CEOManuel Litchman
Employees4
Founded2015
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitemustangbio.com